Increases in the survival rate of men treated with chemotherapeutic drugs and their desire to have children precipitate concerns about the effects of these drugs on germ cells. Azoospermia, oligospermia, and infertility are common outcomes resulting from treatment with cyclophosphamide, an alkylating agent. Exposure of male rats to cyclophosphamide results in dose-dependent and time-specific adverse effects on progeny outcome. Elucidation of the effects of chronic low-dose cyclophosphamide treatment on the expression of stress response genes in male germ cells may provide insight into the mechanisms underlying such adverse effects. Male rats were gavaged with saline or cyclophosphamide (6 mg/kg) for 4-5 wk; pachytene spermatocytes, round spermatids, and elongating spermatids were isolated; RNA was extracted and probed on cDNA arrays containing 216 cDNAs. After saline treatment, 125 stress response genes were expressed in pachytene spermatocytes (57% of genes studied), 122 in round spermatids (56%), and 83 in elongating spermatids (38%). Cyclophosphamide treatment reduced the number of genes detected in all germ cell types. The predominant effect of chronic cyclophosphamide exposure was to decrease the expression level of genes in pachytene spermatocytes (34% of genes studied), round spermatids (29%), and elongating spermatids (4%). In elongating spermatids only, drug treatment increased the expression of 8% of the genes studied. The expression profiles of genes involved in DNA repair, posttranslational modification, and antioxidant defense in male germ cells were altered by chronic cyclophosphamide treatment. We hypothesize that the effects of cyclophosphamide exposure on germ cell gene expression during spermatogenesis may have adverse consequences on male fertility and progeny outcome.
INTRODUCTION
Cancer-related death rates for all cancers combined declined between 1990 and 1997 in the United States [1] . Earlier detection, due to advances in diagnostic technology, and more efficacious treatments have increased patient survival. However, these advances in treatment precipitate other concerns. One such concern is the effects of anticancer agents on the male reproductive system and the potential risks for progeny outcome [2] . Treatment of men with anticancer agents commonly results in male infertility and persistent gonadal damage [3] ; the effect on the quality of spermatozoa remains unclear. Male sterility has led to the use of assisted reproduction techniques, such as intracytoplasmic sperm injection and in vitro fertilization; these approaches may solve infertility problems in cancer survivors but are of increasing concern with respect to their potential impact on progeny [4, 5] .
There is evidence that exposure to drugs or toxicants results in damage to the male genome and induces heritable germ line mutations and malformations [6] . One such chemical is cyclophosphamide, a bifunctional alkylating drug commonly used in chemotherapeutic regimens [7] . The cytotoxicity of cyclophosphamide is mediated by alkylation of DNA at the N7 position of guanine and the formation of DNA-DNA cross-links, DNA-protein crosslinks, and single-strand breaks [8, 9] .
The male reproductive system is particularly sensitive to the damage induced by anticancer agents targeting rapidly dividing cells. The spermatogenic process is highly ordered and regulated; stem cells (spermatogonia) divide mitotically to form spermatocytes to initiate the process. Preleptotene spermatocytes go through two meiotic divisions to become round spermatids. During spermiogenesis, round spermatids differentiate. Changes such as chromatin remodeling, formation of the flagellum, and shedding of most of the cytoplasm take place to form mature spermatozoa [10] .
Cyclophosphamide alters male fertility; treatment with 1-2 mg/kg for more than 4 mo increases the incidence of azoospermia and oligospermia in adult male patients [11] . Previous studies have shown that chronic paternal treatment of rats with cyclophosphamide damages sperm DNA [12] , alters in vitro spermatozoal decondensation [13] , and results in abnormal progeny outcome [14, 15] . The effects of cyclophosphamide on progeny outcome are time specific and dose dependent; maximum postimplantation loss occurs 4 wk after the initiation of treatment, whereas preimplantation loss is prominent at 5-6 wk after the initiation of treatment [16] . Chronic cyclophosphamide treatment alters the histology [17] and biochemistry [18] of the epididymal epithelium, but spermatogenesis is not arrested. Nevertheless, abnormal spermatozoa are found in the lumen of both the epididymis and the testis after chronic cyclophosphamide exposure [17] . The molecular mechanisms underlying the male-mediated developmental toxicity of cyclophosphamide remain to be elucidated.
Identifying the effects of cyclophosphamide treatment on gene expression in germ cells may provide insight into mechanisms underlying the male infertility and male-mediated developmental toxicity of this drug. DNA repair, heat shock proteins, and antioxidant defense mechanisms play an important role in the stress response to alkylating agents [19] and in male germ cell development and functionality. Recently, we reported the differential expression of stress response genes during spermatogenesis [20] and after acute exposure to cyclophosphamide [21] . Maximal adverse effects on progeny outcome were found after low-dose chron-
Numbers of genes expressed in pachytene spermatocytes (top), round spermatids (middle), and elongating spermatids (bottom) after chronic exposure to saline or cyclophosphamide. Spotted circles, number of genes detected exclusively after saline treatment; dashed circles, number of genes detected exclusively after chronic cyclophosphamide treatment. The overlap depicts the number of genes detected in both treatment groups. The boxes depict genes that were expressed exclusively in cells from one treatment group.
ic cyclophosphamide exposure [14, 15] , a common clinical regimen. Therefore, the goal of this study was to assess the effects of chronic cyclophosphamide treatment on the expression of stress response genes in male germ cells.
MATERIALS AND METHODS

Animals
Adult male Sprague-Dawley rats (325-350 g) were obtained from Charles River Canada (St. Constant, QC, Canada), maintained on a 14L: 10D light cycle, and provided with food and water ad libitum. Rats were randomly divided into groups of five animals and gavaged with saline or cyclophosphamide (6 mg/kg) daily, six times per week, for 5-6 wk. At the end of the treatment, rats were killed by decapitation. All animal handling and care were in accordance with the guidelines established by the Canadian Council on Animal Care.
Isolation of Spermatogenic Cell Types
Spermatogenic cells were isolated using the method described by Bellvé et al. [22] , as adapted by Aguilar-Mahecha et al. [20] . Briefly, testes were removed, decapsulated, and incubated with collagenase (C9891; Sigma, Oakville, ON, Canada). After a washing, seminiferous tubules were incubated with trypsin (type 1, T8003; Sigma) and DNase I (type 1, DN-25, Sigma; 1 g/ml), dissociated, and filtered through a nylon mesh (Sefar Canada, Montreal, QC, Canada; 70 m) in the presence of DNase I. A total of 5.6 ϫ 10 8 cells in 25 ml of 0.5% BSA (Sigma) in RPMI (RPMI medium 160; Gibco BRL, Burlington, ON, Canada) was loaded in a velocity sedimentation cell separator apparatus (STA-PUT; Proscience, Don Mills, ON, Canada) and separated by sedimentation velocity. With light microscopy, pachytene spermatocytes, round spermatids, and elongating spermatids were distinguished by their chromatin packaging and morphologic characteristics. Only fractions with high purity (Ͼ85%) were pooled. The average purities for each cell type were pachytene spermatocytes, 91%; round spermatids, 91%; and elongating spermatids, 97%. Five separate cell separations for each treatment were run, each with both testes from one animal.
RNA Extraction
Total RNA extraction was done with phenol-chloroform [23] followed by incubation with RNase-free DNase I (Sigma), for 1 h at 37ЊC, to avoid contamination by genomic DNA. The RNA quality was assessed by gel electrophoresis and spectrophotometric reading.
Probe Preparation and Hybridization to cDNA Atlas Arrays RNA (5 g) was reversed transcribed using Moloney murine leukemia virus reverse transcriptase and radiolabeled with [ 32 P]dATP (10 Ci/l; Amersham Pharmacia Biotech, Baie d'Urfé, QC, Canada). To purify labeled cDNAs from unincorporated 32 P-labeled nucleotides, probes were filtered through CHROMA SPIN-200 DEPC-H 2 O columns (Clontech, Palo Alto, CA). The radioactive probes were added to nylon membranes (Rat Stress and Toxicology Atlas Arrays; Clontech) containing 216 cDNAs spotted in duplicate, and prehybridized with salmon testes DNA and ExpressHyb (Clontech) at 68ЊC; hybridization occurred overnight with continuous agitation at 68ЊC. After 18 h, the arrays were washed three times for 30 min with washing solution 1 (2ϫ saline-sodium citrate [SSC], 1% SDS) and once for 30 min with washing solution 2 (0.1ϫ SSC, 0.5% SDS), with continuous agitation at 68ЊC. After a final wash with 2ϫ SSC at room temperature, the membranes were exposed to a phosphorimager plate for 24 h. Five separate replicates for each cell type and for each treatment were done.
Analysis of Gene Expression
Arrays were visualized after scanning with a phosphorimager (Storm, Molecular Dynamics, Sunnyvale, CA), and the images were imported to AtlasImage software (version 1.5; Clontech) for quantification. The data generated by AtlasImage software were imported into GeneSpring (version 3.2.8; Silicon Genetics, Redwood, CA) for further analysis. The raw signal intensity obtained was the result of the subtraction of the background level on each membrane from that of the intensity of each gene. The threshold for gene detection was set at a raw signal intensity for a given gene of two times the background intensity on that membrane. To minimize experimental variation and permit the comparison of different experiments to one another, an experiment-to-experiment normalization was done (GeneSpring), so that the raw value of a specific gene was divided by the median intensity of that single membrane. This calculation was done for all five replicates and averaged to generate what is referred to as the relative intensity of a specific gene. Changes in gene expression were considered only when the difference in expression level was at least 1.5-fold and consistent in at least three out of five replicate experiments; a 1.5-fold change is equivalent to an increase by 50% or to a decrease by 33%.
RESULTS
Overall Gene Expression
Large numbers of transcripts were detected in all three cell types after saline treatment (Fig. 1) ; 58% of the genes studied were detected in pachytene spermatocytes, 56% in round spermatids, and 38% in elongating spermatids. The lower expression in elongating spermatids was consistent with that found in previous studies [20] . In testicular cells obtained from male rats treated chronically with cyclophosphamide, the numbers of genes detected were reduced slightly; 52% were detected in pachytene spermatocytes, 50% in round spermatids, and 34% in elongating spermatids. Although most of the genes detected in each cell type were expressed in both saline and drug groups, some treatment-specific transcripts were observed. Thirteen genes that were expressed above threshold in pachytene spermatocytes in control animals became undetectable after treatment with cyclophosphamide; similar losses in gene expression were noted for round spermatids (14 genes) and elongating spermatids (13 genes) (Fig. 1, spotted areas) . No genes were expressed selectively after cyclophosphamide treatment in pachytene spermatocytes or round spermatids, whereas four genes displayed intensity values above threshold level in elongating spermatids after cyclophosphamide treatment ( Fig. 1 , dashed areas).
Effects of Chronic Cyclophosphamide Treatment on Gene Expression
Overall changes in gene expression in the different spermatogenic cell types after chronic cyclophosphamide treatment were observed (Fig. 2) . In pachytene spermatocytes, 91 of the 216 genes studied had intensity values below the threshold level ( Fig. 2A) . Transcript levels were not altered (decreased by less than 33%) after cyclophosphamide treatment for 51 of the genes. However, transcript levels for 50 of the genes studied decreased between 33% and 50%, while transcript levels for 24 decreased by 50% or more. Increases in the level of gene expression were not observed in this cell type after chronic cyclophosphamide treatment. Similar to the pattern noted in pachytene spermatocytes, 94 of the genes studied were not expressed in round spermatids (Fig. 2B) . The expression of 59 of the genes remained unchanged after cyclophosphamide treatment. Transcript levels for 37 of the genes studied decreased by between 33% and 50%, while for 26 genes, transcript levels decreased by 50% or more. No increase in gene expression followed cyclophosphamide exposure in this cell type. The effect of cyclophosphamide treatment on elongating spermatids was distinct (Fig. 2C) . Despite the fact that fewer genes were detected in this cell type (83 genes), the majority (58 genes) remained unaffected after drug exposure. A small number of genes had decreased expression levels: expression of six decreased between 33% and 50% and expression of only two decreased by 50% or more. Surprisingly, 17 genes had higher transcript levels after cyclophosphamide treatment, uniquely in elongating spermatids.
Profiles of Gene Expression
Genes were classified according to their response to drug treatment in every cell type. Only expression of those genes that were detected throughout spermatogenesis was profiled; 12 different profiles of expression were obtained (Fig.  3) . The most common response to chronic cyclophosphamide exposure was a decrease in expression in both pachytene spermatocytes and round spermatids with no effect in elongating spermatids (Fig. 3A) . This profile was exhibited for 18 genes, which are involved in posttranslational modification (nine genes); DNA synthesis, recombination, and repair (three genes); DNA and chromatin binding (three genes); cell cycle (two genes); and antioxidant defense (one gene).
The expression of 15 genes was selectively affected in pachytene spermatocytes (Fig. 3) . Of these, expression of extracellular signal-regulated kinase 1 (ERK1) decreased by 51%; while expression of the cell cycle genes cyclin-dependent kinase (CDK) 2-␣ and CDK2-␤ (combined) and cyclin G-associated kinase (GAK) decreased by 41% and 33%, respectively. Round spermatids were also selectively targeted; expression of 11 genes decreased uniquely in round spermatids (Fig. 3) ; expression of apoptosis regulator bcl-x decreased by 63%, while expression of the DNA repair genes proliferating cell nuclear antigen (PCNA) and poly(ADP-ribose) polymerase (PARP) decreased by 37% and 35%, respectively. Other genes affected exclusively in round spermatids included genes that were involved in posttranslational modification (three genes), cell cycle reg- ulation (two genes), and intracellular transduction (one gene). In elongating spermatids, there were fewer effects after drug treatment. Expression of the plectin, ornithine decarboxylase (ODC), and nucleoside diphosphate kinase A (NDKA) genes was unaffected up to midspermatogenesis but increased in elongating spermatids (Fig. 3) ; transcript levels increased by 106%, 98%, and 50%, respectively. Transcripts of the intracellular transducer extracellular signal-regulated kinase 2 (ERK2) and the cell cycle gene p55CDC were the only transcripts to decrease uniquely in mature spermatids after cyclophosphamide treatment (Fig.  3E) ; transcript levels for these genes decreased by 43% and 38%, respectively. Interestingly, drug treatment had opposite effects on the expression of certain genes in different cell types. Nine genes that decreased in expression level in pachytene spermatocytes were unaffected in round spermatids and increased in expression in elongating spermatids after cyclophosphamide treatment (Fig. 3F) . Genes within this pattern included cytoplasmic beta actin (ACTB) and tubulin alpha-1 (TUBA1); expression levels of these genes decreased by 40% and 57%, respectively, in pachytene spermatocytes and increased by 67% and 125%, respectively, in elongating spermatids. The same profile was found for the genes for ribosomal proteins S30 and S19, expression levels of which decreased by 36% and 39%, respectively, in pachytene spermatocytes and increased by 93% and 263%, respectively, in mature spermatids. Similarly, the expression of two genes, the 3-methyladenine DNA glycosylase (MPG) and dual-specific mitogen activated-protein kinase kinase 5 (MAPKK5) genes, was not affected in pachytene spermatocytes, was decreased in round spermatids, and was increased in elongating spermatids (Fig. 3G) . The expression of genes for DNA excision repair cross-complementing in rodents 1 (ERCC1), xeroderma pigmentosum group D complementing protein (XPD), and DNA-binding protein inhibitor ID1 decreased up to midspermatogenesis and increased in mature spermatids (Fig. 3H) .
Cyclophosphamide did not alter the expression of all genes during spermatogenesis; transcript levels for 12 genes remained unaffected by drug treatment (Fig. 3I) Other genes responded similarly in all cell types; p23 and heat shock 10-kDa protein (HSP10) responded to cyclophosphamide with decreased expression in all spermatogenic cell types (Fig. 3J) . The expression of NADPH-cytochrome P450 reductase (CPR), high-mobility group protein 2 (HMG2), and HSP70/HSP90-organizing protein (HOP) was unaffected in pachytene spermatocytes but decreased in round and elongating spermatids (Fig. 3K) . Transcript levels for multidrug resistance protein (MRP) decreased in both pachytene spermatocytes and elongating spermatids but were not affected in round spermatids (Fig. 3L) .
Expression of Gene Families
The response to chronic cyclophosphamide exposure was analyzed in more detail by examining the effect of drug exposure on the expression of different gene families during spermatogenesis.
DNA repair. The effects of chronic cyclophosphamide exposure on the expression of genes involved in different DNA repair pathways were analyzed. The genes affected by drug treatment are depicted in Figure 4 . In pachytene spermatocytes, the levels of expression of DNA repair genes decreased between 38% and 63% with the exception of expression of four genes, which remained unaffected after treatment. In round spermatids, fewer genes were detected, but expression of all decreased from 35% to 73% in response to cyclophosphamide. Surprisingly, in elongating spermatids, the few genes that responded to treatment did so by increasing transcript levels; MPG, XPD, and DNA excision repair protein ERCC1 increased in expression by 249%, 210%, and 96%, respectively.
Heat shock proteins and cochaperones. In pachytene spermatocytes, the expression level of genes for all HSPs detected, except HSP90-beta and HOP, decreased from 35% to 70% after cyclophosphamide treatment (Fig. 5A) . Similar decreases were seen in round spermatids (34%-67%), although expression of HSP60 and HSP70 genes remained unaffected by treatment. In contrast, in elongating spermatids, most of the HSP genes expressed were not affected by drug treatment; decreased expression was seen for HSP10 (44%) and HOP (35%). Interestingly, the only member of this family showing increased expression was HSP70; transcript levels increased by 230% in elongating spermatids after drug treatment.
Expression of cochaperones decreased from 35% to 53% for all genes after cyclophosphamide treatment in pachytene spermatocytes, except for T-complex protein 1 ␣ subunit (TCP1-␣), calreticulin precursor (CALR), and probable protein disulfide isomerase ER60 precursor (Fig. 5B) . In round spermatids, a greater range of decreases was seen; transcript levels were lowered from 35% to 68%, and only one gene, calcium-binding protein 2 (CABP2), did not respond to treatment. In elongating spermatids, expression of most cochaperones was unaffected by drug treatment; only p23 expression decreased, to undetectable levels in treated cells.
Antioxidant defense. Genes involved in antioxidant defense behaved differently after drug treatment in the different cell types (Fig. 6) . In pachytene spermatocytes, all of the genes detected decreased in expression level from 38% to 50%. In contrast, the transcript levels of genes expressed in round spermatids and elongating spermatids were relatively unchanged after treatment. Manganese-containing superoxide dismutase 2 precursor (Mn SOD2) and NAD(P)H:menadione oxidoreductase (NMOR1) were the only genes affected in round spermatids, decreasing by 35% and 46%, respectively. In elongating spermatids, heme oxygenase 1 (HO-1) was the only gene that responded to treatment; HO-1 levels increased from undetectable levels in control cells to reach a relative intensity of 0.30 in treated spermatids, an increase of at least 175%. 
DISCUSSION
Chronic cyclophosphamide exposure resulted in a substantial decrease in gene expression, predominantly in pachytene spermatocytes and round spermatids. This finding contrasts sharply with the effects of acute cyclophosphamide exposure on germ cell gene expression [21] . Acute exposure to cyclophosphamide increases gene expression in all germ cell types, but most dramatically in round spermatids. Increased transcript levels are observed for 30 genes in round spermatids, 7 genes in pachytene spermatocytes, and 2 genes in elongating spermatids [21] . Previous studies have found that exposure to alkylating agents inhibits transcription and translation [24] as well as histone acetylation [25, 26] . An alteration in the transcriptional machinery, as a result of DNA damage, could explain the predominant decrease in gene expression in pachytene spermatocytes and round spermatids after chronic cyclophosphamide treatment. The large number of genes that were unaffected by drug treatment and the different levels of repression observed suggest that the reduction in transcript levels is not due to cytotoxicity but to a more specific response to cyclophosphamide. Alkylation of DNA and protein by cyclophosphamide induces the formation of crosslinks. Cross-links in transcriptionally active regions of the chromosome can cause a pause or arrest of the RNA polymerases, adversely affecting transcription elongation and gene expression [27] . Treatment with nitrogen mustards inhibits the binding to DNA of specific transcription factors [28, 29] , further supporting our observations that changes in the gene expression profile are specific. In elongating spermatids, chromatin is packed tightly after the replacement of histones by protamines, resulting in a transcriptionally inactive cell [30] . The condensed chromatin present at this stage of spermatogenesis may act to protect DNA against drug damage, thus decreasing susceptibility to cyclophosphamide and explaining why the expression of most of the genes detected in elongating spermatids was not altered by chronic drug treatment. Nevertheless, damage has been detected in sperm DNA after chronic cyclophosphamide treatment [12] ; this damage may be induced earlier during spermatogenesis and carried on into mature spermatozoa.
Interestingly, chronic cyclophosphamide exposure induced higher transcript levels uniquely in elongating spermatids. It is unlikely that these transcripts are newly synthesized in elongating spermatids after treatment, since there is normally a lack of transcription during the late phases of spermatogenesis. However, the presence of DNA strand breaks in elongating spermatids may promote an abnormal transcriptional response, increasing transcript steady-state concentrations after drug treatment. The expression of genes in mature spermatids for PCNA and for subunits of the transcription factor TFIIH (XPD and p44); genes involved in replication and transcription, respectively, may play a role in this response.
Stability of RNA may provide an alternate explanation for the elevated transcript levels observed in elongating spermatids. During spermatogenesis, transcriptional and translational control mechanisms allow haploid spermatids to acquire the factors necessary to complete their development [31, 32] . After genes are transcribed in early germ cell types, many mRNAs are bound to ribonucleoproteins and translationally repressed until the protein product is required. Cyclophosphamide may alter the interaction between mRNA and RNA-binding proteins, increasing the stability of the transcripts.
Whereas the predominant effect of acute cyclophosphamide exposure was the induction of gene expression in round spermatids [21] , chronic cyclophosphamide exposure resulted mainly in decreased gene expression. These changes may impact spermatogenesis and sperm function. The decreased expression of cell cycle kinases in pachytene spermatocytes after chronic cyclophosphamide treatment may have important consequences for cell division because of the large number of cyclins with which they interact [33] . Altered meiosis during germ cell development may account for the damage to the synaptonemal complex [34] and the chromosome aberrations [35] observed after mouse spermatocytes are exposed to cyclophosphamide. Disruption of the meiotic process may lead to infertility in transgenic mice [36] , emphasizing the importance of cell cycle regulation for proper germ cell development and fertility.
In round spermatids, PARP and PCNA, two key enzymes involved in DNA repair in response to alkylating agents, are specifically decreased. Inhibition of PARP potentiates the cytotoxicity induced by alkylating agents [37] . PCNA plays a crucial role in nucleotide excision repair, the main pathway of repair of alkylation damage [38] . The ef-fect of cyclophosphamide exposure on progeny outcome reaches maximal plateau levels when germ cells are exposed at the round spermatid stage [14, 15] . The sensitivity of these cells to insult after chronic drug treatment may be enhanced by decreased expression of key DNA repair genes.
Expression of ODC was altered specifically in elongating spermatids after chronic cyclophosphamide exposure. ODC is involved in polyamine synthesis, catalyzing the formation of putrescine, from which spermidine and spermine are synthesized [39] . Polyamines are involved in cell growth and differentiation [40] ; increasing concern about their role in spermatogenesis has emerged since overexpression of ODC has been shown to yield infertile mice [41, 42] , and abnormal levels of polyamines have been found in semen from infertile men [43] . Spermine may be an inhibitory factor of sperm capacitation [44] . The increase in ODC transcript levels in elongating spermatids after chronic cyclophosphamide treatment may be one of the mechanisms by which this drug disturbs sperm function and fertility.
The persistence of genomic damage and DNA breaks in male gametes contributes to male infertility. Male germ cell functionality after cyclophosphamide treatment depends largely on the extent of damage and on the ability of the cell to undergo DNA repair. Unscheduled DNA synthesis, an indirect measure of DNA repair, has been detected after acute treatment with cyclophosphamide in male germ cells up to midspermatogenesis; no unscheduled DNA synthesis was detected in elongating spermatids or spermatozoa [45] . DNA repair genes are differentially expressed during spermatogenesis [20, 46] , and different repair mechanisms can function in germ cells at specific stages of development [47, 48] . Clearly, the expression of DNA repair genes was affected by chronic cyclophosphamide treatment. The marked repression of genes involved in NER, BER, and MMR in pachytene spermatocytes and round spermatids may increase the susceptibility of these cell types to genotoxic damage. In addition, the role of MMR genes in meiotic recombination suggests that their decreased levels of expression after drug treatment, particularly in pachytene spermatocytes, may compromise proper germ cell development and male fertility [49] . Although no DNA repair has been detected in elongating spermatids, transcripts for DNA repair genes were present. The increased expression of DNA repair genes in elongating spermatids after chronic cyclophosphamide treatment may play a role in the repair of damage induced during spermiogenesis. Interestingly, transition protein 1 stimulates the repair of damage induced in spermatids during chromatin remodeling or after genotoxic damage [50] .
To cope with aberrant peptides, the cell is equipped with a posttranslational modification system. HSPs and cochaperones are expressed ubiquitously and induced under a wide range of stressful stimuli, including exposure to cytotoxic antitumor agents [51] . In the testis, HSPs and cochaperones are differentially expressed during spermatogenesis and may have roles both in male germ cell development and in the response to stressful stimuli [20, 52] . Cyclophosphamide may alter protein conformation by binding to proteins and forming DNA-protein cross-links. How the cell responds to proteotoxic stress will depend largely on the expression of HSPs. The decreases in transcripts for HSPs and cochaperones noted after chronic cyclophosphamide treatment suggest that the ability of the cells to repair damaged peptides or properly synthesize proteins is hampered.
The importance of an optimal response to proteotoxic stress in male germ cells is emphasized by the requirement for some of its members for fertility; infertility has been observed in HSP70-2 [53] and calmegin homozygous [54] null male mice. Interestingly, increased levels of HSP70 were detected in elongating spermatids, suggesting an important role of this protein in the response to cyclophosphamide.
Induction of oxidative stress in male germ cells is associated with male infertility [55] . Sperm are highly susceptible to lipid peroxidation, and induction of reactive oxygen species (ROS) is correlated with decreased sperm motility [56, 57] , decreased capacity to undergo the acrosome reaction [58] , and DNA damage [59] . Aitken et al. [60] reported that induction of ROS was associated, in a dosedependent manner, with increased DNA fragmentation in sperm nuclei; however, sperm-egg fusion was affected only in the presence of very high levels of ROS, thus raising concern about the quality of sperm at fertilization. Interestingly, male-mediated developmental toxicity was reported after oxidative stress; prooxidant treatment of male mice induced lethal mutations in offspring, resulting in increased postimplantation loss [61] . The presence of antioxidant defense mechanisms in the testis provides the male gamete with protection against oxidative stress-induced damage. An imbalance between the generation of ROS and the scavenging activities of antioxidants in the male gamete may lead to germ cell damage. Exposure to cyclophosphamide or acrolein, a metabolite of cyclophosphamide, induces the formation of ROS [62, 63] and lipid peroxidation [64] . Chronic cyclophosphamide treatment decreased the expression of all antioxidant genes detected in pachytene spermatocytes; this decrease may contribute to a redox imbalance, increasing the susceptibility of this cell type to oxidative stress.
In conclusion, chronic cyclophosphamide treatment alters the profile of gene expression in the male gamete. Reduced expression of important defense mechanisms after drug treatment may allow damage to accumulate in male germ cells and result in altered sperm function and infertility. The possibilities that damaged sperm can fertilize an egg and that mammalian development may be tolerant to epigenetic abnormalities [65] raise concerns about the male-mediated effects on progeny of drug and toxicant exposure. Whether the abnormal male germ cell gene expression induced by chronic cyclophosphamide exposure is causally related to fetal loss and abnormal development remains to be established.
